As Senior Vice President Data Officer, Trevor is responsible for ensuring that patients and practice maximize the benefit of data by driving FCS digital innovation strategies.He spearheads initiatives to establish improved utilization of data to enhance precision medicine, clinical decision support, valuebased care and quality improvement, as well as data initiatives for research, realworld evidence and clinical trials.Trevor joined FCS in 2020. During his over 30 years of experience, he has held progressively responsible leadership roles in healthcare, life sciences, software and informatics.Trevor completed his Bachelor of Science with honors in Chemistry and Computer Science at the University of Reading in Reading, UK, where he also earned his doctorate in Organic Chemistry. His work has been published in over 30 peer reviewed scientific journals and books
FCS PRECISE: Precision Oncology Clinical Decision Support and Research Solution.
Presentation will discuss the challenges of implementing a precision oncology program at a large community oncology practice. FCS PRECISE, our inhouse precision oncology platform, will be discussed including NGS data standardization, clinical decisionsupport, data profiling and visualization, virtual molecular tumor board capabilities, and clinical trial matching.
Clinical & Research Tools Showcase:
Florida Cancer Spec.
Founded in 1984, Florida Cancer Specialists & Research Institute has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.